|View printer-friendly version|
Spring Bank Pharmaceuticals Appoints Atif Abbas, M.D., as Vice President, Head of Oncology & Immunology Clinical Development
“We are thrilled to have Atif, an innovative and experienced developer of novel oncology and immunology compounds, join
Dr. Abbas is a pharmaceutical physician with nearly 20 years of clinical development, medical affairs and pharmacovigilance experience in oncology and immunology therapeutic areas. Prior to joining
In conjunction with Dr. Abbas’ appointment,
About Spring Bank Pharmaceuticals
LifeSci Advisors, LLC
Source: Spring Bank Pharmaceuticals, Inc.